2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Brain Neoplasms
2
Supranuclear Palsy, Progressive
1
Spinal Cord Injuries
1
Prostatic Neoplasms
1
Parkinson Disease
1
Myasthenia Gravis
1
Multiple System Atrophy
1
Lewy Body Disease
1
Hematologic Neoplasms
1
Head and Neck Carcinoma
1
Fatigue
1
Essential Tremor
1
Carcinoma, Renal Cell
1
Alzheimer Disease
1
Interventions
rozanolixizumab
11
efgartigimod alfa
10
zilucoplan
8
Prednisone
8
Cyclophosphamide
8
ravulizumab
7
Rituximab
7
Pyridostigmine Bromide
7
telitacicept
6
fludarabine
6
Tacrolimus
6
Mycophenolic Acid
6
eculizumab
5
Immunoglobulins, Intravenous
5
Hizentra
4
Azathioprine
4
Steroids
3
HBM9161
3
Data Collection
3
Amifampridine
3
thymoglobulin
2
inebilizumab
2
Thymectomy
2
Prednisolone
2
Methylprednisolone
2
Methotrexate
2
Exercise
2
Diagnostic Self Evaluation
2
Blood Specimen Collection
2
tofacitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myasthenia Gravis
×
Neurofeedback
×
Clear all
NCT02761707
2019-07-18
Biomarkers in Neural Disorders
University of Pennsylvania
Completed
54 enrolled